Eiger BioPharmaceuticals Inc
NASDAQ:EIGR
Income Statement
Earnings Waterfall
Eiger BioPharmaceuticals Inc
Revenue
|
15.8m
USD
|
Cost of Revenue
|
-16k
USD
|
Gross Profit
|
15.8m
USD
|
Operating Expenses
|
-87.5m
USD
|
Operating Income
|
-71.8m
USD
|
Other Expenses
|
-3.2m
USD
|
Net Income
|
-75m
USD
|
Income Statement
Eiger BioPharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
6
+58%
|
9
+53%
|
12
+38%
|
11
-8%
|
13
+18%
|
14
+7%
|
13
-5%
|
15
+11%
|
15
+4%
|
15
-5%
|
16
+8%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
5
+51%
|
8
+50%
|
11
+40%
|
10
-9%
|
12
+20%
|
13
+1%
|
12
-7%
|
13
+12%
|
14
+8%
|
14
+2%
|
16
+9%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(20)
|
(23)
|
(25)
|
(28)
|
(2)
|
5
|
9
|
14
|
(13)
|
(21)
|
(31)
|
(40)
|
(46)
|
(48)
|
(46)
|
(44)
|
(42)
|
(39)
|
(38)
|
(46)
|
(51)
|
(59)
|
(67)
|
(68)
|
(69)
|
(67)
|
(64)
|
(61)
|
(62)
|
(67)
|
(72)
|
(82)
|
(88)
|
(93)
|
(97)
|
(103)
|
(104)
|
(106)
|
(107)
|
(98)
|
(88)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(5)
|
(7)
|
(1)
|
0
|
2
|
4
|
(5)
|
(8)
|
(10)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(12)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(18)
|
(19)
|
(20)
|
(21)
|
(21)
|
(22)
|
(23)
|
(24)
|
(25)
|
(26)
|
(27)
|
(29)
|
(32)
|
(30)
|
(29)
|
(25)
|
|
Research & Development |
(17)
|
(19)
|
(20)
|
(21)
|
(1)
|
4
|
7
|
10
|
(8)
|
(13)
|
(21)
|
(27)
|
(33)
|
(36)
|
(33)
|
(31)
|
(30)
|
(28)
|
(26)
|
(33)
|
(37)
|
(44)
|
(51)
|
(52)
|
(52)
|
(48)
|
(45)
|
(41)
|
(42)
|
(46)
|
(51)
|
(59)
|
(64)
|
(68)
|
(71)
|
(75)
|
(75)
|
(74)
|
(77)
|
(69)
|
(62)
|
|
Operating Income |
(20)
N/A
|
(23)
-17%
|
(25)
-9%
|
(28)
-10%
|
(2)
+95%
|
5
N/A
|
9
+96%
|
14
+58%
|
(13)
N/A
|
(21)
-61%
|
(31)
-51%
|
(40)
-27%
|
(46)
-16%
|
(48)
-5%
|
(46)
+4%
|
(44)
+5%
|
(42)
+5%
|
(39)
+6%
|
(38)
+4%
|
(46)
-21%
|
(51)
-12%
|
(59)
-16%
|
(67)
-13%
|
(68)
-2%
|
(69)
-1%
|
(67)
+3%
|
(64)
+4%
|
(61)
+5%
|
(62)
-2%
|
(63)
-2%
|
(67)
-6%
|
(74)
-10%
|
(77)
-4%
|
(83)
-8%
|
(85)
-2%
|
(90)
-7%
|
(93)
-3%
|
(93)
0%
|
(93)
+0%
|
(84)
+10%
|
(72)
+14%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
0
|
0
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
47
|
47
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
46
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
Pre-Tax Income |
(20)
N/A
|
(24)
-18%
|
(26)
-9%
|
(29)
-11%
|
(2)
+95%
|
5
N/A
|
9
+91%
|
15
+59%
|
(13)
N/A
|
(22)
-67%
|
(33)
-48%
|
(41)
-26%
|
(47)
-14%
|
(49)
-3%
|
(47)
+4%
|
(44)
+5%
|
(42)
+4%
|
(40)
+6%
|
(39)
+3%
|
(47)
-21%
|
(52)
-12%
|
(61)
-16%
|
(68)
-13%
|
(70)
-2%
|
(70)
-1%
|
(68)
+3%
|
(66)
+3%
|
(63)
+4%
|
(65)
-3%
|
(21)
+68%
|
(24)
-19%
|
(31)
-27%
|
(34)
-10%
|
(86)
-153%
|
(88)
-3%
|
(93)
-6%
|
(97)
-4%
|
(97)
0%
|
(96)
+1%
|
(87)
+9%
|
(75)
+13%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(20)
|
(24)
|
(26)
|
(29)
|
(2)
|
5
|
9
|
15
|
(13)
|
(22)
|
(33)
|
(41)
|
(47)
|
(49)
|
(47)
|
(44)
|
(42)
|
(40)
|
(39)
|
(47)
|
(52)
|
(61)
|
(68)
|
(70)
|
(70)
|
(68)
|
(66)
|
(63)
|
(65)
|
(21)
|
(24)
|
(31)
|
(34)
|
(86)
|
(89)
|
(93)
|
(97)
|
(97)
|
(96)
|
(87)
|
(75)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(24)
N/A
|
(28)
-15%
|
(27)
+3%
|
(30)
-11%
|
(2)
+95%
|
5
N/A
|
9
+91%
|
15
+59%
|
(13)
N/A
|
(22)
-67%
|
(33)
-48%
|
(41)
-26%
|
(47)
-14%
|
(49)
-3%
|
(47)
+4%
|
(44)
+5%
|
(42)
+4%
|
(40)
+6%
|
(39)
+3%
|
(47)
-21%
|
(52)
-12%
|
(61)
-16%
|
(68)
-13%
|
(70)
-2%
|
(70)
-1%
|
(68)
+3%
|
(66)
+3%
|
(63)
+4%
|
(65)
-3%
|
(21)
+68%
|
(24)
-19%
|
(31)
-27%
|
(34)
-10%
|
(86)
-153%
|
(89)
-3%
|
(93)
-6%
|
(97)
-4%
|
(97)
0%
|
(96)
+1%
|
(87)
+9%
|
(75)
+13%
|
|
EPS (Diluted) |
-20.3
N/A
|
-34.48
-70%
|
-21.65
+37%
|
-21.41
+1%
|
-8
+63%
|
25.52
N/A
|
48.68
+91%
|
73.7
+51%
|
-63.42
N/A
|
-23.69
+63%
|
-4.65
+80%
|
-5.43
-17%
|
-7.84
-44%
|
-5.81
+26%
|
-5.55
+4%
|
-5.29
+5%
|
-4.86
+8%
|
-3.8
+22%
|
-3.22
+15%
|
-3.28
-2%
|
-3.82
-16%
|
-3.16
+17%
|
-2.92
+8%
|
-2.85
+2%
|
-3.08
-8%
|
-2.78
+10%
|
-2.59
+7%
|
-2.11
+19%
|
-2.31
-9%
|
-0.6
+74%
|
-0.71
-18%
|
-0.91
-28%
|
-1
-10%
|
-2.43
-143%
|
-2.05
+16%
|
-2.12
-3%
|
-2.32
-9%
|
-2.19
+6%
|
-2.18
+0%
|
-1.97
+10%
|
-50.78
-2 478%
|